anneday
11-08-2022, 08:30 AM
Thus patients carrying mutations UGT1A4 48Val and UGT2B7 268Tyr or with wild type UGT2B17 nodel and UGT2B15 523Lys genotypes could be the best candidates for a good response to TAM therapy in terms of inducing effective plasma active TAM metabolite levels doxycycline for pneumonia ([Only registered and activated users can see links])